First demonstration of the role of TNF in the pathogenesis of disease

Journal of Immunology

Volumn 181, Issue 1, 2008, Pages 5-6

  Vilcek, Jan ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

AMINO TERMINAL SEQUENCE; ARTICLE; CYTOKINE PRODUCTION; INFLAMMATORY DISEASE; PATHOGENESIS; PRIORITY JOURNAL; SEPSIS; ANIMAL; GENERAL ASPECTS OF DISEASE; HUMAN; IMMUNOLOGY; INFLAMMATION; METABOLISM; NOTE;

ANIMALS; DISEASE; HUMANS; INFLAMMATION; TUMOR NECROSIS FACTORS;

EID: 47949116902     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.1.5     Document Type: Article

References (14)

1. Beutler, B., I. W. Milsark, and A. C. Cerami. 1985. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229:869-871.
2. Carswell, E. A., L J. Old, R. L. Kassel, S. Green, N. Fiore, and B. Williamson. 1975. An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sri. USA 72: 3666-3670.
3. Kawakami, M., and A. Cerami. 1981. Studies of endoroxin-induced decrease in lipoprotein lipase activity. J. Exp. Med. 154: 631-639.
4. Pekala, P. H., M. Kawakami, C. W. Angus, M. D. Lane, and A. Cerami. 1983. Selective inhibition of synthesis of enzymes for tie novo fatty acid biosynthesis by an endotoxin-induced mediator from exudate cells. Proc. Natl. Acad. Sci. USA 80: 2743-2747.
5. Aggarwal, B. B., W. J. Kohr, P. E. Mass, B. Moffat, S. A. Spencer, \V. J. Henzel, T. S. Bringman, G. E. Nedwin, D. V. Goeddel, and R. N. Harkins. 1985. Human tumor necrosis factor: production, purification, and characterization. J. Biol. Chem. 260:2345-2354.
6. Nedwin, G. E., S. L. Naylor, A. Y. Sakaguchi, D. Smith, J. Jarrett-Nedwin, D. Pennica, D. V. Goeddel, and P. W. Gray. 1985. Human Iymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization. Nucleic Acids Res. 13:6361-6373.
7. Beutler, B., D. Greenwald, J. D. Hulmes, M. Chang, Y.-C. E. Pan, J. Mathison, R. Ulevitch, and A. Cerami. 1985. Identity of tumour necrosis factor and the macrophage-secreted factor cachectin. Nature 316: 552-554.
8. Tracey, K. J., B. Beutler, S. F. Lowry, J. Merryweather, S. Wolpe, I. W. Milsatk, R. J. Hariri, T. J. Fahey, III, A. Zentella, J. D. Albert, et a!. 1986. Shock and tissue injury induced by recombinant human cachectin. Science 234: 470-474.
9. Clark, I. A., J. L. Virelizier, E. A. Carswell, and P. R. Wood. 1981. Possible importance of macrophage-derived mediators in acute malaria. Infect. Immun. 32: 1058-1066.
10. Clark, I. A. 1982. Suggested importance of monokines in pathophysiology of endotoxin shock and malaria. Klin. Wochenschr. 60: 756-758.
11. Riviere, Y., I. Gresser, J.-C. Guillon, and M. G. Tovey. 1977. Inhibition by antiinterferon serum of lymphocytic choriomeningitis virus disease in suckling mice. Proc. NatL Acad. Sci. USA 74: 2135-2139.
12. Vilcek, J., and M. Feldmann. 2004. Historical review: cytokines as therapeutics and targets of therapeutics. Trends Pharmacol. Sci. 25: 201-209.
13. Tracey, K. J., Y. Fong, D. G. Hesse, K. R. Manogue, A. T. Lee, G. C. Kuo, S. F. Lowry, and A. Cerami. 1987. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330: 662-664.
14. Reinhart, K., and W. Karzai. 2001. Anti-tumor necrosis factor therapy in sepsis: update on clinical trials and lessons learned. Crit Care Med. 29: S121-S125.